| Subcribe via RSS
A government regulator is meeting Wednesday to hear an appeal of itsA decision to reject a drug that has proven effective in treating the leading cause ofA vision lossA among Canadians.
Original post by CBC News
(click on the author link above to see full post)As Americans’ waistlines continue to grow, so does the number of people who aren’t getting a good night’s sleep.
Original post by CW33 Dallas KDAF-TV
(click on the author link above to see full post)Judah Folkman, the Harvard Medical School scientist whose research led to a new class of cancer drugs that work by blocking blood supply to tumors, died Monday of a heart attack at age 74.
Original post by Ottawa Citizen
(click on the author link above to see full post)NicOx S.A. has announced it has signed an extension of its March 2006 collaboration agreement, which grants Pfizer Inc the exclusive right to apply its proprietary nitric oxide-donating technology to drug discovery research in the field of ophthalmology.
Original post by Medical News
(click on the author link above to see full post)